Intrauterine, postpartum and adult relationships between arachidonic acid (AA) and docosahexaenoic acid (DHA)

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 85, Issue 5, 2011, Pages 245-252

  Kuipers, Remko S ^a   Luxwolda, Martine F ^a   Janneke Dijck Brouwer, D A ^a   Muskiet, Frits A J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Arachidonic acid; Bioattenuation; Biomagnification; Docosahexaenoic acid; Equilibrium; Pregnancy

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID;

ARTICLE; CARDIOVASCULAR RISK; DELIVERY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BLOOD LEVEL; ERYTHROCYTE; FATTY ACID ANALYSIS; FISH MEAT; HUMAN; LACTATION; LIPID COMPOSITION; MATERNAL NUTRITION; METABOLIC REGULATION; MOTHER CHILD RELATION; PREMATURE LABOR; PRENATAL PERIOD; PRIORITY JOURNAL; PUERPERIUM;

ADULT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY;

EID: 80053589768     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.04.015     Document Type: Article

References (97)

1. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008, 8:349-361.
2. McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005, 82:281-295.
3. F.A. Muskiet, Pathophysiology and evolutionary aspects of dietary fats and long chain polyunsaturated fatty acids across the life cycle, in: J.P. Montmayeur, J. le Coutre (Eds.), Fat Detection. Taste, Texture, and Post-Ingestive Effects, CRC Press Taylor and Francis Group, Boca Raton (USA), pp. 19-79.
4. Braun D.R., Harris J.W., Levin N.E., et al. Early hominin diet included diverse terrestrial and aquatic animals 1.95Ma in East Turkana, Kenya. Proc. Natl. Acad. Sci. U.S.A 2010, 107:10002-10007.
5. Broadhurst C.L., Wang Y., Crawford M.A., Cunnane S.C., Parkington J.E., Schmidt W.F. Brain-specific lipids from marine, lacustrine, or terrestrial food resources: potential impact on early African Homo sapiens. Comp Biochem. Physiol. B Biochem. Mol. Biol. 2002, 131:653-673.
6. Joordens J.C., Wesselingh F.P., de Vos J., Vonhof H.B., Kroon D. Relevance of aquatic environments for hominins: a case study from Trinil (Java, Indonesia). J. Hum. Evol. 2009, 57:656-671.
7. Kuipers R.S., Luxwolda M.F., Dijck-Brouwer D.A., Eaton S.B., Crawford M.A., Cordain L., Muskiet F.A. Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet. Br. J. Nutr. 2010, 104:1666-1687.
8. F.A.J. Muskiet, R.S. Kuipers, Lessons from shore-based hunter-gatherer diets in East Africa, in: S.C. Cunnane, K.M. Stewart (Eds.), Human Brain Evolution-The influence of Freshwater and Marine Food Resources, Wiley-Blackwell, Hoboken, New Jersey, pp. 77-104.
9. Alperson-Afil N., Sharon G., Kislev M., et al. Spatial organization of hominin activities at Gesher Benot Ya'aqov, Israel. Science 2009, 326:1677-1680.
10. Crawford M.A., Hassam A.G., Williams G., Whitehouse W.L. Essential fatty-acids and fetal brain growth. Lancet 1976, 1:452-453.
11. Otto S.J., van Houwelingen A.C., Badart-Smook A., Hornstra G. Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am. J. Clin. Nutr. 2001, 73:1074-1079.
12. Hornstra G. Essential fatty acids in mothers and their neonates. Am. J. Clin. Nutr. 2000, 71:1262S-1269S.
13. Burdge G.C. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:161-168.
14. Carnielli V.P., Simonato M., Verlato G., Luijendijk I., De Curtis M., Sauer P.J., Cogo P.E. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns fed formula with long-chain polyunsaturated fatty acids. Am. J. Clin. Nutr. 2007, 86:1323-1330.
15. Farquharson J. Infant cerebral cortex and dietary fatty acids. Eur. J. Clin. Nutr. 1994, 48(Suppl. 2):S24-S26.
16. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum. Dev. 1980, 4:131-138.
17. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 1980, 4:121-129.
18. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120:S129-S138.
19. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998, 71:2528-2533.
20. Makrides M., Neumann M.A., Byard R.W., Simmer K., Gibson R.A. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 1994, 60:189-194.
21. Rawlings J.S., Rawlings V.B., Read J.A. Prevalence of low birth weight and preterm delivery in relation to the interval between pregnancies among white and black women. N. Engl. J. Med. 1995, 332:69-74.
22. Winkvist A., Rasmussen K.M., Habicht J.P. A new definition of maternal depletion syndrome. Am. J. Public Health 1992, 82:691-694.
23. Bokor S., Koletzko B., Decsi T. Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants. Ann. Nutr. Metab. 2007, 51:550-556.
24. Al M.D., van Houwelingen A.C., Hornstra G. Relation between birth order and the maternal and neonatal docosahexaenoic acid status. Eur. J. Clin. Nutr. 1997, 51:548-553.
25. Foreman-van Drongelen E.E., Zeijdner A.C., van Houwelingen A.D., Kester M.D., Al T.H., Hasaart G. Hornstra, Essential fatty acid status measured in umbilical vessel walls of infants born after a multiple pregnancy. Early Hum. Dev. 1996, 46:205-215.
26. Zeijdner E.E., van Houwelingen A.C., Kester A.D., Hornstra G. Essential fatty acid status in plasma phospholipids of mother and neonate after multiple pregnancy. Prostaglandins Leukot. Essent. Fatty Acids 1997, 56:395-401.
27. Al M.D.M., Vanhouwelingen A.C., Kester A.D.M., Hasaart T.H.M., Dejong A.E.P., Hornstra G. Maternal essential fatty-acid patterns during normal-pregnancy and their relationship to the neonatal essential fatty-acid status. Br. J. Nutr. 1995, 74:55-68.
28. Koletzko B., Lien E., Agostoni C., et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J. Perinat. Med. 2008, 36:5-14.
29. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 2002, 69:15-29.
30. Otto S.J., de Groot R.H., Hornstra G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69:237-243.
31. Freeman M.P., Davis M., Sinha P., Wisner K.L., Hibbeln J.R., Gelenberg A.J. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J. Affect. Disord. 2008, 110:142-148.
32. Freeman M.P. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75:291-297.
33. Llorente A.M., Jensen C.L., Voigt R.G., Fraley J.K., Berretta M.C., Heird W.C. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am. J. Obstet. Gynecol. 2003, 188:1348-1353.
34. Sinclair A.J., Begg D., Mathai M., Weisinger R.S. Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac. J. Clin. Nutr. 2007, 16(Suppl. 1):391-397.
35. Strom M., Mortensen E.L., Halldorsson T.I., Thorsdottir I., Olsen S.F. Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: a prospective study based on a large national birth cohort. Am. J. Clin. Nutr. 2009, 90:149-155.
36. de Groot R.H., Adam J.J., Hornstra G. Selective attention deficits during human pregnancy. Neurosci. Lett. 2003, 340:21-24.
37. Decsi T. Effects of supplementing LCPUFA to the diet of pregnant women: data from RCT. Adv. Exp. Med. Biol. 2009, 646:65-69.
38. Bakker E.C., Ghys A.J., Kester A.D., Vles J.S., Dubas J.S., Blanco C.E., Hornstra G. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7y of age. Eur. J. Clin. Nutr. 2003, 57:89-95.
39. Ghys A., Bakker E., Hornstra G., van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum. Dev. 2002, 69:83-90.
40. Helland I.B., Saugstad O.D., Smith L., Saarem K., Solvoll K., Ganes T., Drevon C.A. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001, 108:E82.
41. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003, 111:e39-e44.
42. Helland I.B., Smith L., Blomen B., Saarem K., Saugstad O.D., Drevon C.A. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008, 122:e472-e479.
43. Simmer K., Patole S.K., Rao S.C. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 2008, CD000376.
44. Simmer K., Schulzke S.M., Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst. Rev. 2008, CD000375.
45. Smithers L.G., Gibson R.A., McPhee A., Makrides M. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. Am. J. Clin. Nutr. 2008, 88:1049-1056.
46. Birch E.E., Carlson S.E., Hoffman D.R., et al. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am. J. Clin. Nutr. 2010, 91:848-859.
47. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47:348-380.
48. M.F. Luxwolda, R.S. Kuipers, W.S. Sango, G. Kwesigabo, D.A. Dijck-Brouwer, F.A. Muskiet, A maternal erythrocyte DHA content of 6 g% is the DHA status at which intrauterine DHA biomagnification turns into bioattenuation and postnatal infant DHA equilibrium is reached, submitted for publication.
49. R.S. Kuipers, M.F. Luxwolda, D.A. Dijck-Brouwer, W.S. Sango, G. Kwesigabo, F.A. Muskiet, Maternal DHA equilibrium during pregnancy and lactation is reached at an erythrocyte DHA content of 8 g/100 g fatty acids, J. Nutr. 141 (2011) 418-427.
50. Elias S.L., Innis S.M. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am. J. Clin. Nutr. 2001, 73:807-814.
51. Crawford M.A., Golfetto I., Ghebremeskel K., et al. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 2003, 38:303-315.
52. Montgomery C., Speake B.K., Cameron A., Sattar N., Weaver L.T. Maternal docosahexaenoic acid supplementation and fetal accretion. Br. J. Nutr. 2003, 90:135-145.
53. Vlaardingerbroek H., Hornstra G. Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids. Prostaglandins Leukot. Essent. Fatty Acids 2004, 71:363-374.
54. van Beusekom C.M., Nijeboer H.J., van der Veere C.N., Luteyn A.J., Offringa P.J., Muskiet F.A., Boersma E.R. Indicators of long chain polyunsaturated fatty acid status of exclusively breastfed infants at delivery and after 20-22 days. Early Hum. Dev. 1993, 32:207-218.
55. Carlson S.E., Werkman S.H., Peeples J.M., Cooke R.J., Tolley E.A. Arachidonic acid status correlates with first year growth in preterm infants. Proc. Natl. Acad. Sci. U.S.A 1993, 90:1073-1077.
56. Woltil H.A., van Beusekom C.M., Schaafsma A., Muskiet F.A., Okken A. Long-chain polyunsaturated fatty acid status and early growth of low birth weight infants. Eur. J. Pediatr. 1998, 157:146-152.
57. Farquharson J., Cockburn F., Patrick W.A., Jamieson E.C., Logan R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992, 340:810-813.
58. Haggarty P. Effect of placental function on fatty acid requirements during pregnancy. Eur. J. Clin. Nutr. 2004, 58:1559-1570.
59. Haggarty P. Placental regulation of fatty acid delivery and its effect on fetal growth-a review. Placenta 2002, 23(Suppl. A):S28-S38.
60. Neerhout R.C. Alteration of adult erythrocyte lipids during in vivo fetal circulation. Pediatr. Res. 1971, 5:683-690.
61. Neerhout R.C. Erythrocyte lipids in the neonate. Pediatr. Res. 1968, 2:172-178.
62. Kuipers R.S., Smit E.N., van der Meulen J., Janneke Dijck-Brouwer D.A., Rudy Boersma E., Muskiet F.A. Milk in the island of Chole (Tanzania) is high in lauric, myristic, arachidonic and docosahexaenoic acids, and low in linoleic acid reconstructed diet of infants born to our ancestors living in tropical coastal regions. Prostaglandins Leukot. Essent. Fatty Acids 2007, 76:221-233.
63. Hsieh A.T., Brenna J.T. Dietary docosahexaenoic acid but not arachidonic acid influences central nervous system fatty acid status in baboon neonates. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:105-110.
64. Dunstan J.A., Mori T.A., Barden A., et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur. J. Clin. Nutr. 2004, 58:429-437.
65. Judge M.P., Harel O., Lammi-Keefe C.J. A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 2007, 42:117-122.
66. Malcolm C.A., Hamilton R., McCulloch D.L., Montgomery C., Weaver L.T. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest. Ophthalmol. Vis. Sci. 2003, 44:3685-3691.
67. Malcolm C.A., McCulloch D.L., Montgomery C., Shepherd A., Weaver L.T. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch. Dis. Child. Fetal Neonatal. Ed. 2003, 88:F383-F390.
68. Cheruku S.R., Montgomery-Downs H.E., Farkas S.L., Thoman E.B., Lammi-Keefe C.J. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am. J. Clin. Nutr. 2002, 76:608-613.
69. McNamara R.K. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:223-231.
70. Chiu C.C., Su K.P., Cheng T.C., et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1538-1544.
71. Bourre J.M. Dietary omega-3 Fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J. Nutr. Health Aging 2005, 9:31-38.
72. Lin P.Y., Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J. Clin. Psychiatry 2007, 68:1056-1061.
73. Ross B.M., Seguin J., Sieswerda L.E. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?. Lipids Health Dis. 2007, 6:21.
74. Innis S.M. Human milk: maternal dietary lipids and infant development. Proc. Nutr. Soc. 2007, 66:397-404.
75. Jicha G.A., Markesbery W.R. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin. Interv. Aging 2010, 5:45-61.
76. Helland I.B., Saugstad O.D., Saarem K., van Houwelingen A.C., Nylander G., Drevon C.A. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. J. Matern. Fetal Neonatal. Med. 2006, 19:397-406.
77. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105:1897-1903.
78. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
79. Kris-Etherton P.M., Harris W.S., Appel L.J., American Heart Association Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
80. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. J. Am. Med. Assoc. 2006, 296:1885-1899.
81. Block R.C., Harris W.S., Reid K.J., Sands S.A., Spertus J.A. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008, 197:821-828.
82. Harris W.S., Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev. Med. 2004, 39:212-220.
83. Kris-Etherton P.M., Grieger J.A., Etherton T.D. Dietary reference intakes for DHA and EPA. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:99-104.
84. Park Y., Lim J., Lee J., Kim S.G. Erythrocyte fatty acid profiles can predict acute non-fatal myocardial infarction. Br. J. Nutr. 2009, 102:1355-1361.
85. Von Schacky C. Cardiovascular disease prevention and treatment. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81:193-198.
86. Eaton S.B., Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl. J. Med. 1985, 312:283-289.
87. Cordain L., Eaton S.B., Sebastian A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81:341-354.
88. Neuringer M., Connor W.E., Van Petten C., Barstad L. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest. 1984, 73:272-276.
89. Bjerve K.S., Fischer S., Wammer F., Egeland T. alpha-Linolenic acid and long-chain omega-3 fatty acid supplementation in three patients with omega-3 fatty acid deficiency: effect on lymphocyte function, plasma and red cell lipids, and prostanoid formation. Am. J. Clin. Nutr. 1989, 49:290-300.
90. Smit E.N., Oelen E.A., Seerat E., Boersma E.R., Muskiet F.A. Fish oil supplementation improves docosahexaenoic acid status of malnourished infants. Arch. Dis. Child. 2000, 82:366-369.
91. Decsi T., Zaknun D., Zaknun J., Sperl W., Koletzko B. Long-chain polyunsaturated fatty acids in children with severe protein-energy malnutrition with and without human immunodeficiency virus-1 infection. Am. J. Clin. Nutr. 1995, 62:1283-1288.
92. Payet M., Esmail M.H., Polichetti E., et al. Docosahexaenoic acid-enriched egg consumption induces accretion of arachidonic acid in erythrocytes of elderly patients. Br. J. Nutr. 2004, 91:789-796.
93. DeLany J.P., Vivian V.M., Snook J.T., Anderson P.A. Effects of fish oil on serum lipids in men during a controlled feeding trial. Am. J. Clin. Nutr. 1990, 52:477-485.
94. Reis G.J., Pasternak R.C. Fish oil supplements and restenosis after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1990, 66:385-386.
95. Horrobin D.F., Jenkins K., Bennett C.N., Christie W.W. Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:83-90.
96. R.S. Kuipers, M.F. Luxwolda, W.S. Sango, G. Kwesigabo, D.A. Dijck-Brouwer,F.A. Muskiet, The relation between DHA and AA is synergistic at low DHA status and antagonistic at high DHA status, in: Proceedings of ISSFAL Maastricht 2010 Congress Book Poster Presentation and Oral Presentation, 2010.
97. Astorg P., Arnault N., Czernichow S., Noisette N., Galan P., Hercberg S. Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women. Lipids 2004, 39:527-535.